Qi-Xang Li Crown Bioscience Inc. Biography Publications Institution JoVE Articles Qi-Xang Li has not added a biography. If you are Qi-Xang Li and would like to personalize this page please email our Author Liaison for assistance. Publications Anti‑cancer Effects of a Novel Pan‑RAF Inhibitor in a Hepatocellular Carcinoma Cell Line Molecular Medicine Reports. Apr, 2018 | Pubmed ID: 29484394 EGFR Gene Status Predicts Response and Survival Benefit in a Preclinical Gastric Cancer Trial Treating Patient‑derived Xenografts with Cetuximab Oncology Reports. Oct, 2017 | Pubmed ID: 28849161 Experimental Animal Modeling for Immuno-oncology Pharmacology & Therapeutics. May, 2017 | Pubmed ID: 28167217 Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor Molecular Cancer Therapeutics. 04, 2017 | Pubmed ID: 27903750 Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines Cancer Research. 08, 2016 | Pubmed ID: 27325646 Design and Synthesis of Novel 3-sulfonylpyrazol-4-amino Pyrimidines As Potent Anaplastic Lymphoma Kinase (ALK) Inhibitors Bioorganic & Medicinal Chemistry Letters. Apr, 2016 | Pubmed ID: 26979157 Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines As Potent Anaplastic Lymphoma Kinase (ALK) Inhibitors Bioorganic & Medicinal Chemistry Letters. Jun, 2015 | Pubmed ID: 26130408 同所性同種 (同系) マウスのプライマリ KPC 膵管腺癌のフローサイトメトリーによる診療 Xiaoyu An*1,2, Xuesong Ouyang*1, Hui Zhang1, Tingting Li1, Yu-yang Huang1, Zhiyuan Li1, Demin Zhou2, Qi-Xang Li1,2 1Crown Bioscience Inc., 2State Key Laboratory of Natural and Biomimetic Drugs, Peking University JoVE 57460 암 연구학
同所性同種 (同系) マウスのプライマリ KPC 膵管腺癌のフローサイトメトリーによる診療 Xiaoyu An*1,2, Xuesong Ouyang*1, Hui Zhang1, Tingting Li1, Yu-yang Huang1, Zhiyuan Li1, Demin Zhou2, Qi-Xang Li1,2 1Crown Bioscience Inc., 2State Key Laboratory of Natural and Biomimetic Drugs, Peking University JoVE 57460 암 연구학